Dalfopristin/quinupristin Drug Interactions
Currently displaying 236 drugs known to have a moderate interaction with dalfopristin / quinupristin.
Moderate interactions with dalfopristin / quinupristin
Note: Showing generic names only.
A
- abemaciclib
- adagrasib
- alfuzosin
- aliskiren
- alprazolam
- amlodipine
- apixaban
- aprepitant
- aripiprazole
- atazanavir
- atorvastatin
- avacopan
- axitinib
B
C
- cabazitaxel
- cabozantinib
- cannabis
- capmatinib
- carbamazepine
- cariprazine
- ceritinib
- cerivastatin
- cevimeline
- chlordiazepoxide
- chloroquine
- chlorotrianisene
- clarithromycin
- clobazam
- clonazepam
- clorazepate
- cocaine nasal
- cocaine topical
- conjugated estrogens
- conjugated estrogens topical
- copanlisib
- cortisone
- crizotinib
- cyclobenzaprine
- cyclophosphamide
- cyclosporine
D
- daclatasvir
- dapsone
- daridorexant
- darifenacin
- dasatinib
- delavirdine
- dexamethasone
- diazepam
- dienestrol topical
- diethylstilbestrol
- dihydroergotamine
- diltiazem
- docetaxel
- dofetilide
- dronedarone
- drospirenone
- dutasteride
- duvelisib
E
- efavirenz
- elagolix
- eletriptan
- enfortumab vedotin
- enzalutamide
- ergonovine
- ergotamine
- estazolam
- esterified estrogens
- estradiol
- estradiol topical
- estrone
- estropipate
- estropipate topical
- eszopiclone
- ethinyl estradiol
- ethosuximide
- etonogestrel
- etoposide
- etrasimod
- etravirine
F
- fecal microbiota, live
- fedratinib
- felodipine
- fesoterodine
- fludrocortisone
- flurazepam
- fluticasone
- fluticasone nasal
- fosaprepitant
- fostamatinib
G
H
I
- ibrutinib
- idelalisib
- ifosfamide
- imatinib
- indinavir
- indium oxyquinoline in-111
- irinotecan
- irinotecan liposomal
- isavuconazonium
- isradipine
- istradefylline
- itraconazole
- ixabepilone
K
L
- lansoprazole
- lapatinib
- larotrectinib
- lefamulin
- leniolisib
- levamlodipine
- levobupivacaine
- levoketoconazole
- levonorgestrel
- lidocaine
- loratadine
- lorlatinib
- losartan
- lovastatin
M
- macitentan
- maraviroc
- medroxyprogesterone
- megestrol
- methadone
- methylergonovine
- methylprednisolone
- methysergide maleate
- mibefradil
- miconazole
- midazolam
- midostaurin
- mifepristone
- mirtazapine
- mitapivat
N
- naldemedine
- nefazodone
- nelfinavir
- nevirapine
- nicardipine
- nifedipine
- nilotinib
- nimodipine
- nisoldipine
- nitisinone
- norethindrone
- norgestrel
O
P
- paclitaxel
- paclitaxel protein-bound
- palbociclib
- panobinostat
- pazopanib
- pimavanserin
- pioglitazone
- pirtobrutinib
- polatuzumab vedotin
- ponatinib
- pralsetinib
- prednisolone
- prednisone
- progesterone
- progesterone topical
- propafenone
Q
R
- red yeast rice
- repaglinide
- ribociclib
- rilpivirine
- rimegepant
- ripretinib
- ritonavir
- rivaroxaban
- roflumilast topical
- rucaparib
S
- saquinavir
- saxagliptin
- sertraline
- sildenafil
- silodosin
- simvastatin
- sirolimus
- sirolimus topical
- solifenacin
- sparsentan
- stiripentol
- sufentanil
T
- tadalafil
- tamsulosin
- tasimelteon
- temsirolimus
- tepotinib
- testosterone
- testosterone topical
- tiagabine
- ticagrelor
- tisotumab vedotin
- tofacitinib
- tolterodine
- tolvaptan
- toremifene
- trabectedin
- tramadol
- triamcinolone
- triazolam
- troleandomycin
U
V
- valdecoxib
- vamorolone
- vardenafil
- venlafaxine
- verapamil
- vilazodone
- vinblastine
- vincristine
- vincristine liposome
- vinorelbine
- voxelotor
Z
Dalfopristin/quinupristin disease interactions
There are 2 disease interactions with dalfopristin / quinupristin which include:
More about dalfopristin / quinupristin
- dalfopristin/quinupristin consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: streptogramins
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.